| Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia CD DiNardo, K Pratz, V Pullarkat, BA Jonas, M Arellano, PS Becker, ... Blood, The Journal of the American Society of Hematology 133 (1), 7-17, 2019 | 1610 | 2019 |
| A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia SI Lee, S Celik, BA Logsdon, SM Lundberg, TJ Martins, VG Oehler, ... Nature communications 9 (1), 42, 2018 | 314 | 2018 |
| Cancer-and chemotherapy-induced anemia GM Rodgers, PS Becker, M Blinder, D Cella, A Chanan-Khan, C Cleeland, ... Journal of the National Comprehensive Cancer Network 10 (5), 628-653, 2012 | 281 | 2012 |
| Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia X Chen, H Xie, BL Wood, RB Walter, JM Pagel, PS Becker, VK Sandhu, ... J Clin Oncol 33 (11), 1258-1264, 2015 | 270 | 2015 |
| Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia H Kantarjian, P Fenaux, MA Sekeres, PS Becker, A Boruchov, D Bowen, ... Journal of Clinical Oncology 28 (3), 437-444, 2010 | 223 | 2010 |
| Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. PS Becker, M Wagle, S Matous, RS Swanson, G Pihan, PA Lowry, ... Biology of blood and marrow transplantation: journal of the American Society …, 1997 | 213 | 1997 |
| Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ SK Nilsson, ME Debatis, MS Dooner, JA Madri, PJ Quesenberry, ... Journal of Histochemistry & Cytochemistry 46 (3), 371-377, 1998 | 211 | 1998 |
| Stem cell homing: rolling, crawling, and nesting PJ Quesenberry, PS Becker Proceedings of the National Academy of Sciences 95 (26), 15155-15157, 1998 | 209 | 1998 |
| Development and validation of a novel acute myeloid leukemia–composite model to estimate risks of mortality ML Sorror, BE Storer, AT Fathi, AT Gerds, BC Medeiros, P Shami, ... JAMA oncology 3 (12), 1675-1682, 2017 | 161 | 2017 |
| Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status PS Becker, SK Nilsson, Z Li, VM Berrios, MS Dooner, CL Cooper, C Hsieh, ... Experimental hematology 27 (3), 533-541, 1999 | 161 | 1999 |
| Myeloid growth factors, version 2.2017, NCCN clinical practice guidelines in oncology J Crawford, PS Becker, JO Armitage, DW Blayney, J Chavez, P Curtin, ... Journal of the National Comprehensive Cancer Network 15 (12), 1520-1541, 2017 | 136 | 2017 |
| A phase 1 study of lucatumumab, a fully human anti‐CD 40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma W Bensinger, RT Maziarz, S Jagannath, A Spencer, S Durrant, PS Becker, ... British journal of haematology 159 (1), 58-66, 2012 | 136 | 2012 |
| Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: long term follow‐up from a phase 1b study DA Pollyea, K Pratz, A Letai, BA Jonas, AH Wei, V Pullarkat, M Konopleva, ... American journal of hematology 96 (2), 208-217, 2021 | 119 | 2021 |
| The effect of mild diamide oxidation on the structure and function of human erythrocyte spectrin. PS Becker, CM Cohen, SE Lux Journal of Biological Chemistry 261 (10), 4620-4628, 1986 | 118 | 1986 |
| Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer I Baik, WJ DeVito, K Ballen, PS Becker, W Okulicz, Q Liu, E Delpapa, ... Cancer Research 65 (1), 358-363, 2005 | 112 | 2005 |
| Fully human Bcma targeted chimeric antigen receptor T cells administered in a defined composition demonstrate potency at low doses in advanced stage high risk multiple myeloma DJ Green, M Pont, BD Sather, AJ Cowan, CJ Turtle, BG Till, ... Blood 132 (Supplement 1), 1011-1011, 2018 | 110 | 2018 |
| Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation M Alsina, PS Becker, X Zhong, A Adams, P Hari, S Rowley, ... Biology of Blood and Marrow Transplantation 20 (8), 1183-1189, 2014 | 108 | 2014 |
| The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells VM Berrios, GJ Dooner, G Nowakowski, A Frimberger, H Valinski, ... Experimental hematology 29 (11), 1326-1335, 2001 | 106 | 2001 |
| Clofarabine with high dose cytarabine and granulocyte colony‐stimulating factor (G‐CSF) priming for relapsed and refractory acute myeloid leukaemia PS Becker, HM Kantarjian, FR Appelbaum, SH Petersdorf, B Storer, ... British journal of haematology 155 (2), 182-189, 2011 | 103 | 2011 |
| A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells GS Nowakowski, MS Dooner, HM Valinski, AM Mihaliak, PJ Quesenberry, ... Stem cells 22 (6), 1030-1038, 2004 | 101 | 2004 |
